Position in TARS
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$385,825
-$64,515 QoQ
Shares Held
5,500
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in TARS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Valmark Advisers, Inc. holds $452,302 across 2 Biotechnology names. TARS ranks #1 (85.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TARS |
Tarsus Pharmaceuticals, Inc.
This page
|
5,500 | $385,825 | |
| 2 | CELU |
Celularity Inc
|
49,983 | $66,477 |
All Filings in TARS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $385,825 | 5,500 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $450,340 | 5,500 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $326,865 | 5,500 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $222,805 | 5,500 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $282,535 | 5,500 | Shares | Sole | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||